Company: NCEL
Filing Date: 2025-02-10
Form Type: F-3
Source: 0001213900-25-011823
Chunk: 124

Company: NewcelX Ltd.
Filing Date: 2025-02-10
Form: F-3
Chunk 124
---
 ● | negotiated prices. |

We will set forth in a prospectus supplement the
terms of the offering of securities, including:

| ● | the name or names of any agents, dealers or underwriters; |

| ● | the purchase price of the securities being offered and the proceeds we will receive from the sale; |

| ● | any over-allotment options under which underwriters may purchase additional securities from us; |

| ● | any agency fees or underwriting discounts and other items constituting agents’ or underwriters’ compensation; |

| ● | the public offering price; |

| ● | any discounts or concessions allowed or re-allowed or paid to dealers; and |

| ● | any securities exchanges or markets on which such securities may be listed. |

<div align='center'>84</div>

If underwriters are used in the sale, they will
acquire the securities for their own account and may resell the securities from time to time in one or more transactions at a fixed public
offering price or at varying prices determined at the time of sale. The obligations of the underwriters to purchase the securities will
be subject to the conditions set forth in the applicable underwriting agreement. We may offer the securities to the public through underwriting
syndicates represented by managing underwriters or by underwriters without a syndicate. Subject to certain conditions, the underwriters
will be obligated to purchase all of the securities offered by the prospectus supplement, other than securities covered by any over-allotment
option. Any public offering price and any discounts or concessions allowed or re-allowed or paid to dealers may change from time to time.
We may use underwriters with whom we have a material relationship. We will describe in the prospectus supplement, naming the underwriter,
the nature of any such relationship.

We may sell securities directly or through agents
we designate from time to time. We will name any agent involved in the offering and sale of securities and we will describe any commissions
we will pay the agent in the prospectus supplement. Unless the prospectus supplement states otherwise, our agent will act on a best-efforts
basis for the period of its appointment.

We may also sell securities directly to one or
more purchasers without using underwriters or agents.

Underwriters, dealers and agents that participate
in the distribution of the securities may be underwriters as defined in the Securities Act and any discounts or commissions they receive
from us and any profit on their resale of the securities may be treated as underwriting